Our academic collaborators’ seminal contributions push the field forward
Our constellation of renowned thinkers and partners
The right collaborators across pharma, biotech and nonprofit
The next generation of scientific leaders in cancer immunotherapy
Stories & Announcements
PICI in the News
From Bench to Fireside
01
Parker Institute for Cancer Immunotherapy and Cancer Vaccine Coalition Unite to Accelerate Cancer Prevention and Treatment as Momentum Builds for Cancer Vaccines
02
Dr. Rebecca A Sager Named Recipient of PICI’s Inaugural Endowed Young Investigator Award
03
Parker Institute for Cancer Immunotherapy Brings the Power of Its Integrated Network to ASCO 2026
Develop breakthrough immune therapies to turn all cancers into curable diseases faster
The driving force behind PICI’s research and operations
Join us. Change lives.
Accelerate Breakthrough Research – From Discovery to Commercialization
A fundamental challenge in cancer research is how to bring the best ideas to the marketplace, as complex intellectual property and patent processes can be hard to navigate. Enter PICI. Our legal experts and financial support help our investigators turn their discoveries into treatments. We evaluate a discovery’s potential, ensure patent applications are compelling, and help optimize and negotiate licensing. This catalyzes their discoveries to make a real impact for patients faster.
350+
Invention Disclosures Reviewed
Inventions Supported
patent applications supported
licensed inventions
We have extensive expertise in immuno-oncology patents and licensing and provide strategic guidance and advice throughout the process. Contact us for advice or more information on immuno-oncology technologies available for licensing.
PICI offers a unique combination of expertise, resources and capabilities.